Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Satavaptan in SIADH
NCT00264927Phase 3Completed
- Sponsor
- Sanofi
- Start
- May 2004
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 11
01
Overview
Phase 3, randomised, double-blind trial in syndrome of inappropriate antidiuretic hormone secretion (SIADH) comparing Satavaptan with Placebo (2 arms). Primary endpoint: Serum sodium. Started May 2004; status: completed.
02
Drugs
satavaptan
03
Conditions
syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Beyond the preview
Go deeper on NCT00264927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00264927.